Prevention of radial artery occlusion with rivaroxaban after interventional coronary interventions using transradial access: Results of a single-center randomized clinical trial
- 26 September 2026
- journal article
- research article
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (6) , 2907-2915
Abstract
Background: Transradial access is the preferred approach for coronary angiography and percutaneous coronary intervention; however, radial artery occlusion (RAO) remains the most common vascular complication and may preclude repeat radial access, radiocephalic arteriovenous fistula creation, and use of the radial artery as a coronary bypass conduit. Most preventive strategies target procedural factors, whereas extended pharmacologic prophylaxis remains insufficiently studied. Objective: To evaluate the efficacy of rivaroxaban 2.5 mg twice daily for 3 months in preventing RAO after transradial coronary procedures and to assess bleeding events during follow-up. Methods: This prospective, single-center, open-label randomized controlled trial enrolled 300 patients with chronic coronary syndrome undergoing coronary angiography or percutaneous coronary intervention via conventional transradial access. Patients were randomized (1:1) to rivaroxaban 2.5 mg twice daily for 3 months or standard therapy without additional anticoagulation. Duplex ultrasound, performed by a blinded assessor at 7 days, 1 month, and 3 months, evaluated the primary endpoint of complete RAO. Bleeding was classified according to Bleeding Academic Research Consortium criteria. Adjusted associations were assessed using Firth penalized logistic regression. Results: Rivaroxaban significantly reduced RAO at 7 days (0.7% vs 12.7%; p < 0.001), 1 month (3.3% vs 14.7%; p < 0.001), and 3 months (4.0% vs 13.3%; p = 0.004). At 3 months, the absolute risk reduction was 9.3%, corresponding to a number needed to treat of approximately 11. After adjustment for chronic kidney disease, radial artery diameter, and procedure duration, rivaroxaban remained independently associated with lower RAO (adjusted OR 0.22, 95% CI 0.08–0.61; p = 0.003). No BARC type 3–5 bleeding occurred; four BARC type 1 events were observed. Conclusions: In this selected single-center population, prolonged low-dose rivaroxaban was associated with a substantial reduction in ultrasound-detected RAO after transradial coronary procedures. These findings support further multicenter placebo-controlled trials but do not justify routine prophylactic use pending additional safety, cost-effectiveness, and comparative-effectiveness data.Keywords
This publication has 14 references indexed in Scilit:
- Radial vs femoral access for percutaneous coronary intervention: temporal trends and outcomes in the USAEuropean Heart Journal, 2025
- Distal Versus Conventional Radial Access for Coronary Angiography and InterventionJACC: Cardiovascular Interventions, 2022
- Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkersDiabetologia, 2021
- Post-procedural radial artery occlusion and patency detection using duplex ultrasound vs. the reverse Barbeau testEuropean Heart Journal Supplements, 2020
- Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Radial Artery Occlusion – Incidence, Predictors and Long-term outcome after TRAnsradial Catheterization: clinico-Doppler ultrasound-based study (RAIL-TRAC study)Acta Cardiologica, 2017
- Prevention of Radial Artery Occlusion After Transradial CatheterizationJACC: Cardiovascular Interventions, 2016
- Comparison of A Priori Versus Provisional Heparin Therapy on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis (from the PHARAOH Study)The American Journal of Cardiology, 2012
- Efficacy and Safety of Transient Ulnar Artery Compression to Recanalize Acute Radial Artery Occlusion After Transradial CatheterizationThe American Journal of Cardiology, 2011
- Comparison of the Effect of Intra-Arterial Versus Intravenous Heparin on Radial Artery Occlusion After Transradial CatheterizationThe American Journal of Cardiology, 2009